Myleofibrosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Myleofibrosis}} {{CMG}} ==Overview== ==Medical Therapy== Myleofibrosis has no known cure. Lenalidomide (brand name Revlimid) and Thalidomide are drugs..." |
No edit summary |
||
| Line 9: | Line 9: | ||
Myleofibrosis has no known cure. [[Lenalidomide]] (brand name Revlimid) and [[Thalidomide]] are drugs that can be used in its treatment, though they can cause [[gout]] and leave the patient susceptible to diseases such as [[pneumonia]]. Frequent [[blood transfusions]] may also be required. | Myleofibrosis has no known cure. [[Lenalidomide]] (brand name Revlimid) and [[Thalidomide]] are drugs that can be used in its treatment, though they can cause [[gout]] and leave the patient susceptible to diseases such as [[pneumonia]]. Frequent [[blood transfusions]] may also be required. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 15:27, 21 September 2012
|
Myleofibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myleofibrosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Myleofibrosis medical therapy |
|
Risk calculators and risk factors for Myleofibrosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
Myleofibrosis has no known cure. Lenalidomide (brand name Revlimid) and Thalidomide are drugs that can be used in its treatment, though they can cause gout and leave the patient susceptible to diseases such as pneumonia. Frequent blood transfusions may also be required.